RxDoctor Payments Data

Melissa Graves, MD

Family Medicine · Keyser, WVNPI 1891907549

Payments from drug & device makers

$1,124in general payments, 2019–2025

Across 63 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$340
  • Exact Sciences$163
  • AstraZeneca$156
  • Johnson & Johnson$95
  • Phathom Pharmaceuticals, Inc.$62
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$50
  • plus $258 from 13 others

What the payments were for

  • Food & beverage$1,124100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,124 in reported general payments places this provider in the 70th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$62,237
Medicare patients
166
Services billed
760

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban65$93,027
OzempicSemaglutide56$64,444
FarxigaDapagliflozin Propanediol40$47,348
TrulicityDulaglutide30$42,466
MounjaroTirzepatide30$35,040
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$29,488
XareltoRivaroxaban31$26,377
Tresiba Flextouch U-100Insulin Degludec45$25,836
Tresiba Flextouch U-200Insulin Degludec12$25,743
Xigduo XrDapaglifloz Propaned/Metformin20$19,459
JardianceEmpagliflozin16$17,478
CreonLipase/Protease/Amylase12$13,005
Breo ElliptaFluticasone/Vilanterol23$12,991
MovantikNaloxegol Oxalate13$5,332
Albuterol Sulfate HfaAlbuterol Sulfate122$4,971

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$32$93,02765 claims
Lilly USA, LLCTrulicity, Mounjaro$12$77,50660 claims
Novo NordiskOzempic$340$64,44456 claims
AstraZenecaFarxiga$156$47,34840 claims
Johnson & JohnsonXarelto$95$26,37731 claims
Boehringer IngelheimJardiance$14$17,47816 claims
AbbVieCreon, Synthroid$19$15,19337 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Keyser

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →